Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 23, 2017

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Hepatitis C Virus Infection
Interventions
DRUG

SOF/VEL

400/100 mg FDC tablet(s) administered orally once daily

Trial Locations (16)

110029

All India Institute of Medical Sciences, Delhi

110070

Institute of Liver and Biliary Sciences, New Delhi

141001

Dayanand Medical College & Hospital, Ludhiana

160012

Post Graduate Institute of Medical Education and Resesarch (PGIMER), Chandigarh

226014

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

395002

Nirmal Hospital, Surat

400012

Seth GS Medical College and KEM hospital, Mumbai

Global Hospital-Super Speciality & Transpant Centre (A Unite of Centre for Digestive & Kidney Diseases (India) PVT LTD., Mumbai

440003

Government Medical College & Super Speciality Hospital, Nagpur

500003

Gandhi Hospital, Secunderabad

500004

Global Hospitals, Hyderabad

600010

YRG Care, Chennai

641005

VGM Hospital - Institute of Gastroenterology, Coimbatore

682040

Lakeshore Hospital, Kochi

700020

Department of Hepatology, School of Digestive and Liver Diseases, Kolkata

781006

Institute of Digestive and Liver Disease, Guwahati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY